Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Adjustments to Additional Paid in Capital, Warrant Issued

1.5 / 5 stars · 16/52 Roast Me

ALPHA TEKNOVA, INC. Adjustments to Additional Paid in Capital, Warrant Issued

ALPHA TEKNOVA, INC. (TKNO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.

Financial Statements › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-02

  • ALPHA TEKNOVA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00.
  • ALPHA TEKNOVA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $0.00.
  • ALPHA TEKNOVA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • ALPHA TEKNOVA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $0.00.
  • ALPHA TEKNOVA, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $132.00K.
Period endAdjustments to Additional Paid in Capital, Warrant IssuedAdjustments to Additional Paid in Capital, Warrant Issued 3 monthAdjustments to Additional Paid in Capital, Warrant Issued 6 monthAdjustments to Additional Paid in Capital, Warrant Issued 9 monthAdjustments to Additional Paid in Capital, Warrant Issued 12 month
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
$0.00
derived: sum of 4 quarters · filed 2026-03-02
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$0.00
10-Q · filed 2025-08-08
$0.00
derived: sum of 3 quarters · filed 2026-03-02
$0.00
derived: sum of 4 quarters · filed 2026-03-02
2025-03-31$0.00
10-Q · filed 2025-05-09
$0.00
derived: sum of 2 quarters · filed 2026-03-02
$0.00
derived: sum of 3 quarters · filed 2026-03-02
$0.00
derived: sum of 4 quarters · filed 2026-03-02
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$0.00
derived: sum of 2 quarters · filed 2026-03-02
$0.00
derived: sum of 3 quarters · filed 2026-03-02
$132.00K
10-K · filed 2026-03-02
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$132.00K
10-Q · filed 2025-11-07
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$132.00K
10-Q · filed 2025-08-08
2024-03-31$132.00K
10-Q · filed 2025-05-09
2024-03-08$100.00K
10-K · filed 2025-03-07
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$0.00
derived: sum of 2 quarters · filed 2024-11-08
$0.00
10-Q · filed 2024-11-08
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$0.00
10-Q · filed 2024-08-13
2023-03-31$0.00
10-Q · filed 2024-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92